Agilon Health, Inc. (AGL)
84.14
+1.86
(+2.26%)
USD |
NYSE |
Oct 02, 16:00
84.28
+0.14
(+0.17%)
Pre-Market: 20:00
Agilon Health Max Drawdown (5Y) : 99.27% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.27% |
| August 31, 2026 | 99.27% |
| July 31, 2026 | 99.27% |
| June 30, 2026 | 99.27% |
| May 31, 2026 | 99.27% |
| April 30, 2026 | 99.27% |
| March 31, 2026 | 99.27% |
| February 28, 2026 | 99.18% |
| January 31, 2026 | 98.81% |
| Date | Value |
|---|---|
| December 31, 2025 | 98.81% |
| November 30, 2025 | 98.81% |
| October 31, 2025 | 98.16% |
| September 30, 2025 | 98.00% |
| August 31, 2025 | 98.00% |
| July 31, 2025 | 96.37% |
| June 30, 2025 | 96.37% |
| May 31, 2025 | 96.37% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Astrana Health, Inc. | 84.80% |
| Starling Oncology, Inc. | 98.83% |
| Nakamoto, Inc. | -- |
| American Oncology Network, Inc. | 99.83% |
| Tenet Healthcare Corp. | 58.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -67.97 |
| Beta (5Y) | 2.976 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 145.1% |
| Historical Sharpe Ratio (5Y) | -0.2632 |
| Historical Sortino (5Y) | -0.7452 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.08% |